4.7 Article

The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

World Stroke Organization (WSO): Global Stroke Fact Sheet 2022

Valery L. Feigin et al.

Summary: Stroke is the second-leading cause of death and the third-leading cause of death and disability worldwide. It imposes a significant economic burden, particularly in lower-income and lower-middle-income countries. The provided information serves as an updated resource for communication with stakeholders.

INTERNATIONAL JOURNAL OF STROKE (2022)

Article Chemistry, Medicinal

? Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKII? Hub Domain

Yongsong Tian et al.

Summary: This study identified the CaMKIIα hub domain as a high-affinity target and synthesized a series of analogues, with the oxygen-bridged analogue 4d showing promising affinity and stability, making it a potential drug candidate with enhanced pharmacokinetic properties.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Preservation of vision after CaMKII-mediated protection of retinal ganglion cells

Xinzheng Guo et al.

Summary: The study shows that reactivating the CaMKII-CREB signaling pathway can protect retinal ganglion cells (RGCs) from injuries, promoting RGC survival and protecting long-distance RGC axon projections in glaucoma models. Additionally, CaMKII activity is important for RGC survival in the normal retina.
Article Multidisciplinary Sciences

GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain

Ulrike Leurs et al.

Summary: This study demonstrates the selective binding of compounds related to GHB to CaMKIIα, leading to increased thermal stability of the hub and providing neuroprotection, particularly under pathological conditions. This unexpected interaction establishes GHB analogs as powerful tools for investigating CaMKII neuropharmacology in general and as potential therapeutic compounds for cerebral ischemia.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Neurosciences

Sustained Baclofen-Induced Activation of GABAB Receptors After Cerebral Ischemia Restores Receptor Expression and Function and Limits Progressing Loss of Neurons

Mohammad Hleihil et al.

Summary: The activation of GABA(B) receptors with baclofen provides neuroprotection against excitotoxic death in cerebral ischemia. Sustained activation stabilizes receptor expression and reduces downregulation under excitotoxic conditions, preserving GABA(B) receptor-mediated inhibition. This restoration of GABA(B) receptors enhances neuronal survival and function, making them promising targets for neuroprotection in acute cerebral ischemia.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Review Clinical Neurology

The future of neuroprotection in stroke

Angel Chamorro et al.

Summary: This article discusses research on neuroprotection, including the evaluation of potential neuroprotectants in preclinical models and some attempts in clinical trials. Some new developments and compounds show promise for improving neuroprotection, but further research and testing are needed.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Pharmacology & Pharmacy

The γ-hydroxybutyric acid (GHB) analogue NCS-382 is a substrate for both monocarboxylate transporters subtypes 1 and 4

Louise Thiesen et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

Heterogeneity in human hippocampal CaMKII transcripts reveals allosteric hub-dependent regulation

Roman Sloutsky et al.

SCIENCE SIGNALING (2020)

Article Biochemistry & Molecular Biology

The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca2+/CaM

Melanie H. Wong et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Review Biochemistry & Molecular Biology

The role of Ca2+-calmodulin stimulated protein kinase II in ischaemic stroke - A potential target for neuroprotective therapies

John A. P. Rostas et al.

NEUROCHEMISTRY INTERNATIONAL (2017)

Article Pharmacology & Pharmacy

In Vitro and In Vivo Evidence for Active Brain Uptake of the GHB Analog HOCPCA by the Monocarboxylate Transporter Subtype 1

Louise Thiesen et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)

Article Pharmacology & Pharmacy

GHB receptor targets in the CNS: Focus on high-affinity binding sites

Tina Bay et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Review Neurosciences

Mechanisms of CaMKII action in long-term potentiation

John Lisman et al.

NATURE REVIEWS NEUROSCIENCE (2012)

Review Chemistry, Multidisciplinary

CaMKII in cerebral ischemia

Steven J. Coultrap et al.

ACTA PHARMACOLOGICA SINICA (2011)

Article Neurosciences

Excitotoxic neuroprotection and vulnerability with CaMKII inhibition

Nicole M. Ashpole et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2011)

Review Cell Biology

Calcium, ischemia and excitotoxicity

Kinga Szydlowska et al.

CELL CALCIUM (2010)

Article Biochemistry & Molecular Biology

Effective Post-insult Neuroprotection by a Novel Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Inhibitor

Rebekah S. Vest et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke

Andrew N. Clarkson et al.

NATURE (2010)

Article Biochemistry & Molecular Biology

Intersubunit capture of regulatory segments is a component of cooperative CaMKII activation

Luke H. Chao et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)

Article Clinical Neurology

Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia

Bo Gao et al.

CEREBROVASCULAR DISEASES (2008)

Article Cell Biology

Dual mechanism of a natural CaMKII inhibitor

Rebekah S. Vest et al.

MOLECULAR BIOLOGY OF THE CELL (2007)

Article Biochemistry & Molecular Biology

Oligomerization states of the association domain and the holoenyzme of Ca2+/CaM kinase II

OS Rosenberg et al.

FEBS JOURNAL (2006)

Article Pharmacology & Pharmacy

Novel cyclic γ-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain

P Wellendorph et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Neurosciences

Effect of γ-hydroxybutyrate in two rat models of focal cerebral damage

A Ottani et al.

BRAIN RESEARCH (2003)

Article Pharmacology & Pharmacy

Stereo selectivity of NCS-382 binding to γ-hydroxybutyrate receptor in the rat brain

MP Castelli et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2002)

Article Multidisciplinary Sciences

Interaction with the NMDA receptor locks CaMKII in an active conformation

KU Bayer et al.

NATURE (2001)

Article Pharmacology & Pharmacy

A photothrombotic model of small early ischemic infarcts in the rat brain with histologic and MRI correlation

PH Pevsner et al.

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2001)